ClinicalTrials.Veeva

Menu

Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia

U

University of Padova

Status

Enrolling

Conditions

Anesthesia Brain Monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT06349681
CONOXBird

Details and patient eligibility

About

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia.

It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.

Full description

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia.

It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bwtween the 2 indicies, as well as with EMG, Concentration of Propofol (CeP) and Remifentanil (CeR) during Total Intravenous Anesthesia with Target Controlled Infusion (TIVA-TCI).

Enrollment

14 estimated patients

Sex

Female

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld or Schnider model) and Remifentanil (Minto model) and CONOX monitoring

Exclusion criteria

  • Neurological disease
  • Psychiatric disease
  • Obesity
  • Locoregional anesthesia

Trial contacts and locations

1

Loading...

Central trial contact

Federico Linassi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems